CLINICAL CASE OF THE COMBINED ANTITHROMBOTIC THERAPY IN CASE OF ACUTE CORONARY SYNDROME WITH ATRIAL FIBRILLATION // BSU bulletin. Medicine and pharmacy. - 2019. №3. . - С. 56-62.

CLINICAL CASE OF THE COMBINED ANTITHROMBOTIC THERAPY IN CASE OF ACUTE CORONARY SYNDROME WITH ATRIAL FIBRILLATION

DOI: 10.18101/2306-1995-2019-3-56-62 UDK: 616.132.2:616.12-008.313.2

The comorbidity of atrial fibrillation (AF) and acute coronary syndrome (ACS) often occurs in clinical practice. The treatment of ACS prescribes double antiplatelet thera- py (DAT). The presence of AF makes it necessary to prevent thromboembolic com- plications (FS) through the appointment of oral anticoagulants (UAC). In the pres- ence of simultaneous indications for taking antiplatelet agents and oral anticoagulant, it is necessary to choose the optimal combination. The number of antiplatelet agents and oral anticoagulants has recently expanded significantly, the results of studies on the antithrombotic efficacy and safety of new oral anticoagulants in patients with AF, different combinations of antiplatelet agents in dual antiplatelet therapy (DAP) in ACS, different combinations of antiplatelet agents and anticoagulants in ACS in a patient with AF have been published. In each clinical case of combined pathology of ACS and AF, the doctor has to implement a personalized approach when prescribing combined AAT.

acute coronary syndrome, atrial fibrillation, antithrombotic therapy, antiplatelet therapy, thromboembolic complications, double antiplatelet therapy, oral an- ticoagulant.